Last update 20 Mar 2025

Human Albumin(Hualan Biological Engineering)

Overview

Basic Info

Drug Type
Blood components
Synonyms
human albumin(Hualan Biological Engineering)
Target
albumin
Action
agonists
Mechanism
albumin agonists(Serum albumin agonists)
Therapeutic Areas
Hemic and Lymphatic DiseasesOther Diseases
Active Indication
Anemia, HemolyticHemorrhageHypoalbuminemia+ [1]
Inactive Indication-
Originator Organization
Hualan Biological Engineering, Inc.Hualan Biological Engineering, Inc.
Active Organization
Hualan Biological Engineering, Inc.Hualan Biological Engineering, Inc.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (31 Dec 1995),
Anemia, HemolyticHemorrhageHypoalbuminemia+ [1]
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Human Albumin(Hualan Biological Engineering)
ChiCTR2400094058
/ SuspendedNot ApplicableIIT
Effect of early perioperative target directed infusion of human blood albumin on postoperative complications in patients with oral cancer undergoing free flap transplantation
100 Clinical Results associated with Human Albumin(Hualan Biological Engineering)
Login to view more data
100 Translational Medicine associated with Human Albumin(Hualan Biological Engineering)
Login to view more data
100 Patents (Medical) associated with Human Albumin(Hualan Biological Engineering)
Login to view more data
100 Deals associated with Human Albumin(Hualan Biological Engineering)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anemia, Hemolytic
China
Hualan Biological Engineering, Inc.Hualan Biological Engineering, Inc.
31 Dec 1995
Hemorrhage
China
Hualan Biological Engineering, Inc.Hualan Biological Engineering, Inc.
31 Dec 1995
Hypoalbuminemia
China
Hualan Biological Engineering, Inc.Hualan Biological Engineering, Inc.
31 Dec 1995
Hypovolemia
China
Hualan Biological Engineering, Inc.Hualan Biological Engineering, Inc.
31 Dec 1995
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free